Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases
US-9580412-B2 · Feb 28, 2017 · US
This patent family groups 3 related publications across US. Members often share priority claims or equivalent filings in different countries.
| Field | Value |
|---|---|
| Family ID | 45809111 |
| Family type | — |
| Earliest priority | Oct 28, 2011 |
| First filing country | US |
| Member publications | 3 |
| Countries | US |
| Representative publication | US9580412B2 — Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases |
Best representative member for this family based on priority and filing country.
US9580412B2 — Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases (published Feb 28, 2017)
Related publications in this family.
US-9580412-B2 · Feb 28, 2017 · US
US-2016362403-A1 · Dec 15, 2016 · US
US-9388149-B2 · Jul 12, 2016 · US